Initial clinical experience of ranibizumab therapy for neovascular age-related macular degeneration

PURPOSE: To describe the visual acuity and safety outcomes for the first 50 patients with neovascular age-related macular degeneration (nAMD) treated with ranibizumab at Moorfields Eye Hospital. METHODS: A retrospective analysis of case notes from the first 50 consecutive patients with Primary Care...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotsos, Tryfon, Patel, Praveen J, Chen, Fred K, Tufail, Adnan
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993128/
https://www.ncbi.nlm.nih.gov/pubmed/21151333
http://dx.doi.org/10.2147/OPTH.S14684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993128/
https://www.ncbi.nlm.nih.gov/pubmed/21151333
http://dx.doi.org/10.2147/OPTH.S14684

Ejemplares similares